Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongliang Wei

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Cancer Research and Clinical Oncology|September 11, 2022
Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanomaYunteng Wu, Dongliang Wei, Guoxin Ren, et al.
Seminars in Cancer Biology|December 6, 2025
Microbiota and cancer immunotherapy: Mechanisms, clinical implications, and precision therapeuticsDongliang Wei, Yilan Sun, Jing Han, et al.
Frontiers in Immunology|December 18, 2024
Integrating omics data and machine learning techniques for precision detection of oral squamous cell carcinoma: evaluating single biomarkersYilan Sun, Guozhen Cheng, Dongliang Wei, et al.
Journal of Cancer|February 19, 2024
The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinomaRongrong Hui, Xiulan Liu, Zongyu Fan, et al.
Cancer Medicine|August 17, 2022
The association between body mass index and efficacy of pembrolizumab as second-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinomaXinyi Zhang, Mengyu Rui, Chao Lin, et al.
ACS Nano|December 2, 2024
Photoreversible Color-Switching Cu-Doped TiO<sub>2</sub> Nanoparticles for High-Contrast Rewritable PrintingWenshou Wang, Dongliang Wei, Yun Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 27, 2021
The baseline oral microbiota predicts the response of locally advanced oral squamous cell carcinoma patients to induction chemotherapy: A prospective longitudinal studyMengyu Rui, Xinyi Zhang, Jinyun Huang, et al.
Complementary Therapies in Medicine|August 26, 2025
Tuina improves patellofemoral osteoarthritis by alleviating the degree of lateral patellar tilt: a correlation analysis based on a randomized controlled trialJinguang Gu, Yongli Dong, Guangcheng Wei, et al.
Medcomm|July 26, 2023
A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinomaHouyu Ju, Dongliang Wei, Yunteng Wu, et al.
American Journal of Cancer Research|March 21, 2020
TLR4 activation leads to anti-EGFR therapy resistance in head and neck squamous cell carcinomaHouyu Ju, Zhenrong Hu, Yusheng Lu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Cancer Research and Clinical Oncology|September 11, 2022
Chemotherapy in combination with anti-PD-1 agents as adjuvant therapy for high-risk oral mucosal melanomaYunteng Wu, Dongliang Wei, Guoxin Ren, et al.
Seminars in Cancer Biology|December 6, 2025
Microbiota and cancer immunotherapy: Mechanisms, clinical implications, and precision therapeuticsDongliang Wei, Yilan Sun, Jing Han, et al.
Frontiers in Immunology|December 18, 2024
Integrating omics data and machine learning techniques for precision detection of oral squamous cell carcinoma: evaluating single biomarkersYilan Sun, Guozhen Cheng, Dongliang Wei, et al.
Journal of Cancer|February 19, 2024
The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinomaRongrong Hui, Xiulan Liu, Zongyu Fan, et al.
Cancer Medicine|August 17, 2022
The association between body mass index and efficacy of pembrolizumab as second-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinomaXinyi Zhang, Mengyu Rui, Chao Lin, et al.
ACS Nano|December 2, 2024
Photoreversible Color-Switching Cu-Doped TiO<sub>2</sub> Nanoparticles for High-Contrast Rewritable PrintingWenshou Wang, Dongliang Wei, Yun Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 27, 2021
The baseline oral microbiota predicts the response of locally advanced oral squamous cell carcinoma patients to induction chemotherapy: A prospective longitudinal studyMengyu Rui, Xinyi Zhang, Jinyun Huang, et al.
Complementary Therapies in Medicine|August 26, 2025
Tuina improves patellofemoral osteoarthritis by alleviating the degree of lateral patellar tilt: a correlation analysis based on a randomized controlled trialJinguang Gu, Yongli Dong, Guangcheng Wei, et al.
Medcomm|July 26, 2023
A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinomaHouyu Ju, Dongliang Wei, Yunteng Wu, et al.
American Journal of Cancer Research|March 21, 2020
TLR4 activation leads to anti-EGFR therapy resistance in head and neck squamous cell carcinomaHouyu Ju, Zhenrong Hu, Yusheng Lu, et al.
Pageof 2